Holen Sie sich die Stockscreener-App
86.38
0.07%
-0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$86.44
Offen:
$86.55
24-Stunden-Volumen:
35.10M
Relative Volume:
3.94
Marktkapitalisierung:
$110.49B
Einnahmen:
$36.36B
Nettoeinkommen (Verlust:
$4.84B
KGV:
23.18
EPS:
3.7261
Netto-Cashflow:
$5.43B
1W Leistung:
-2.55%
1M Leistung:
-6.29%
6M Leistung:
-0.29%
1J Leistung:
-9.53%
1-Tages-Spanne:
$85.59
$87.94
1-Wochen-Bereich:
$85.22
$89.53
52-Wochen-Spanne:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Fortgesetzt | Barclays | Overweight |
| 2026-02-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
AMA approves permanent CPT codes for Medtronic's devices treating urinary incontinence and hypertension. - Pluang
Medtronic receives Category I CPT code approvals for two devices - Investing.com India
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems - Medtronic
Medtronic options flow dominated by large December put spread - Investing.com
Medtronic Sees Unusually High Options Volume (NYSE:MDT) - MarketBeat
Medtronic stock after-hours at EUR 76.62: plus 0.05 percent versus prior close - AD HOC NEWS
Medtronic drug-coated balloon gets FDA breakthrough status - MedTech Dive
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? - Yahoo Finance
Medtronic reveals cardiac mapping and ablation software clearances - Yahoo Finance
Medtronic Lands FDA Breakthrough Tag and Dual Cardiac Clearances as MiniMed Exchange Offer Looms - AD HOC NEWS
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade. - The Motley Fool
Medtronic raises fiscal 2027 outlook for Medtronic stock - AD HOC NEWS
Medtronic Reveals Regulatory Milestones for Software Used With Cardiac Ablation Platforms - marketscreener.com
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research
Medtronic Named to Fortune 2026 'Change the World' List for Touch Surgery(TM) Ecosystem and Healthy Neighbor - ACCESS Newswire
Medtronic gains regulatory clearances for cardiac software By Investing.com - Investing.com Canada
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software - PR Newswire
Medtronic's (MDT) Buy Rating Reaffirmed at TD Cowen - MarketBeat
Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Form 425 Medtronic plc Filed by: Medtronic plc - StreetInsider
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
[425] Medtronic plc Business Combination Communication - Stock Titan
Medtronic stock at USD 88.29 on September 28, 2026 - AD HOC NEWS
Medtronic plc stock at USD 88.64 on September 25, 2026 - AD HOC NEWS
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? - Yahoo Finance
Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing? - Yahoo Finance
Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets? - Insider Monkey
Medtronic Couples Bedside Ultrasound Push With Robotics Bet as MiniMed Split Nears Finish Line - AD HOC NEWS
Medtronic Extends 49-Year Dividend Streak as Stealth AXiS Debuts in European Operating Rooms - AD HOC NEWS
Medtronic Marks 49 Straight Years of Dividend Growth While MiniMed Spinoff Takes Shape - AD HOC NEWS
[425] Medtronic plc Business Combination Communication | MDT SEC FilingForm 425 - Stock Titan
Medtronic PLC's Dividend Analysis - GuruFocus
Medtronic stock trades at USD 88.51 after Q1 growth - AD HOC NEWS
Medtronic stock heads into the open after a 0.88 percent drop - AD HOC NEWS
Medtronic Lifts Guidance as FDA Clears Robot Instrument and MiniMed Spinoff Advances - AD HOC NEWS
Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine? - Yahoo Finance
Medtronic stock falls 1.62 percent after raised FY27 guidance - AD HOC NEWS
Medtronic PLC $MDT Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Medtronic stock heads into the open after a 1.62 percent drop - AD HOC NEWS
Medtronic PLC $MDT Shares Sold by QRG Capital Management Inc. - MarketBeat
Here's Why Medtronic (MDT) Fell More Than Broader Market - Yahoo Finance
Medtronic stock closes lower at the close - AD HOC NEWS
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Medtronic: Buy The 3% Yield And Strong Free Cash Flow Growth (NYSE:MDT) - Seeking Alpha
Medtronic (MDT): Q1 Beat Sparks Target Hikes, but Wall Street Splits on Re-Rating Case - Yahoo Finance
Medtronic plc (MDT) Options ChainYahoo Finance - Yahoo! Finance Canada
Medtronic: The Turnaround Is No Longer Quiet (NYSE:MDT) - Seeking Alpha
Medtronic stock holds near USD 91 as margins draw attention - AD HOC NEWS
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
Medtronic plc (MDT) latest stock news and headlines - Yahoo Finance Singapore
Andra AP fonden Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):